Published in J Eur Acad Dermatol Venereol on November 26, 2012
Photographing the Skin During Photodynamic Therapy | NCT03167762
European guidelines for topical PDT part 1 JEADV 2013; 27: 536-544. J Eur Acad Dermatol Venereol (2013) 1.07
Current evidence and applications of photodynamic therapy in dermatology. Clin Cosmet Investig Dermatol (2014) 0.96
The dermatoscopic universe of basal cell carcinoma. Dermatol Pract Concept (2014) 0.95
Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin Cancer. Int J Mol Sci (2015) 0.86
Primary care review of actinic keratosis and its therapeutic options: a global perspective. Dermatol Ther (Heidelb) (2015) 0.85
Effect of methylene blue-mediated photodynamic therapy for treatment of basal cell carcinoma. Lasers Med Sci (2014) 0.81
Topical PDT in the Treatment of Benign Skin Diseases: Principles and New Applications. Int J Mol Sci (2015) 0.81
Drug delivery nanoparticles in skin cancers. Biomed Res Int (2014) 0.80
Long-term recurrence of nonmelanoma skin cancer after topical methylaminolevulinate photodynamic therapy in a dermato-oncology department. An Bras Dermatol (2015) 0.79
Photodynamic Therapy and Non-Melanoma Skin Cancer. Cancers (Basel) (2016) 0.78
Photodynamic Therapy Followed by Mohs Micrographic Surgery Compared to Mohs Micrographic Surgery Alone for the Treatment of Basal Cell Carcinoma: Results of a Pilot Single-Blinded Randomised Controlled Trial. J Cutan Aesthet Surg (2015) 0.76
Response to Letter to the editor: 'European guidelines for topical PDT part 1. JEADV 2013;27:536-544' DOI: 10.1111/jdv.12258. J Eur Acad Dermatol Venereol (2014) 0.76
Photodynamic therapy in Bowen disease of the first web space of the hand. Ann Dermatol (2015) 0.76
A 10-Year Retrospective Analysis of Methyl Aminolevulinate Photodynamic Therapy Consultation at the Hospital de Braga. Dermatol Ther (Heidelb) (2016) 0.75
Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia. Australas J Dermatol (2015) 0.75
Is There a Relationship between the Stratum Corneum Thickness and That of the Viable Parts of Tumour Cells in Basal Cell Carcinoma? J Skin Cancer (2016) 0.75
Light-based therapies in acne treatment. Indian Dermatol Online J (2015) 0.75
Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments. PLoS One (2017) 0.75
Enhanced efficiency of cell death by lysosome-specific photodamage. Sci Rep (2017) 0.75
Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol (2007) 4.61
Langerhans cells as primary target cells for HIV infection. Lancet (1987) 2.97
Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. Br J Dermatol (2013) 2.70
Studies on human epidermal Langerhans cells. I. Allo-activating and antigen-presenting capacity. Scand J Immunol (1980) 2.09
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo. Br J Dermatol (2011) 1.75
Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol (2013) 1.60
Antigen presentation by vascular endothelial cells and epidermal Langerhans cells: the role of HLA-DR. Immunol Rev (1982) 1.51
Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Am J Clin Dermatol (2001) 1.48
Sporadic hypomelanosis of Ito with focal hypertrichosis in a 16-month-old girl. Dermatology (1996) 1.45
Expression of interleukin-12 is increased in psoriatic skin. J Invest Dermatol (1998) 1.43
The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy (2004) 1.42
Increased metal allergy in patients with failed metal-on-metal hip arthroplasty and peri-implant T-lymphocytic inflammation. Allergy (2009) 1.37
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) (2008) 1.32
Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells. Antimicrob Agents Chemother (2005) 1.31
Non-Langerhans cell histiocytoses. A new unifying concept. Am J Dermatopathol (1996) 1.29
Eosinophils and atopic dermatitis. Allergy (2004) 1.25
Skin ageing. J Eur Acad Dermatol Venereol (2011) 1.21
Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol (1999) 1.17
Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermatol (2002) 1.11
Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin Exp Allergy (2000) 1.11
Studies on human epidermal Langerhans' cells: II. Activation of human T lymphocytes to herpes simplex virus. Acta Derm Venereol (1980) 1.09
Human epidermal Langerhans cells induce cellular immune response to trichophytin in dermatophytosis. Br J Dermatol (1983) 1.07
Human afferent lymph from normal skin contains an increased number of mainly memory / effector CD4(+) T cells expressing activation, adhesion and co-stimulatory molecules. Eur J Immunol (2000) 1.06
Deep penetrating dermatofibroma versus dermatofibrosarcoma protuberans. A clinicopathologic comparison. Am J Surg Pathol (1994) 1.02
Daylight photodynamic therapy for actinic keratosis: an international consensus: International Society for Photodynamic Therapy in Dermatology. J Eur Acad Dermatol Venereol (2011) 1.02
Cutaneous nocardiosis caused by Nocardia brasiliensis after an insect bite. Dermatology (1999) 1.00
Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts. Br J Dermatol (2004) 0.99
Determination of the antibacterial efficacy of a new porphyrin-based photosensitizer against MRSA ex vivo. Photochem Photobiol Sci (2007) 0.97
Perforin and granzyme B may contribute to skin inflammation in atopic dermatitis and psoriasis. Br J Dermatol (2001) 0.96
Eosinophilic esophagitis in adults--no clinical relevance of wheat and rye sensitizations. Allergy (2006) 0.95
Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies. Br J Dermatol (2009) 0.94
Photodynamic therapy of multiple actinic keratoses: reduced pain through use of visible light plus water-filtered infrared A compared with light from light-emitting diodes. Br J Dermatol (2010) 0.93
Indocyanine green-augmented diode laser treatment of port-wine stains: clinical and histological evidence for a new treatment option from a randomized controlled trial. Br J Dermatol (2012) 0.93
Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities. Br J Dermatol (2008) 0.93
HLA-DR-expressing Langerhans'-like cells in vaginal and cervical epithelium. Acta Obstet Gynecol Scand (1983) 0.92
Studies on human epidermal langerhans cells. IV. HLA-D restriction of langerhans cell-dependent antigen activation of T lymphocytes. Scand J Immunol (1982) 0.92
Cyclophosphamide-dexamethasone pulsed therapy for treatment of recalcitrant necrobiotic xanthogranuloma with paraproteinemia and ocular involvement. Br J Dermatol (2005) 0.91
The impact of the pH value on skin integrity and cutaneous wound healing. J Eur Acad Dermatol Venereol (2009) 0.90
Chronic cutaneous infection caused by Mycobacterium gordonae. Dermatology (1993) 0.89
Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. J Allergy Clin Immunol (2000) 0.89
Photodynamic therapy for skin field cancerization: an international consensus. International Society for Photodynamic Therapy in Dermatology. J Eur Acad Dermatol Venereol (2012) 0.88
European guidelines for topical photodynamic therapy part 2: emerging indications--field cancerization, photorejuvenation and inflammatory/infective dermatoses. J Eur Acad Dermatol Venereol (2012) 0.88
Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GALEN platform. The Galenda project. Allergy (2009) 0.88
Primary cutaneous cryptococcosis and secondary antigenemia in a patient with long-term corticosteroid therapy. Infection (2005) 0.87
Co-culture of human keratinocytes on post-mitotic human dermal fibroblast feeder cells: production of large amounts of interleukin 6. J Invest Dermatol (1992) 0.87
The antigen-presenting function of human Langerhans cells. Immunobiology (1984) 0.87
Human epidermal Langerhans cells are more potent than blood monocytes in inducing some antigen-specific T-cell responses. Br J Dermatol (1983) 0.86
Studies on human epidermal Langerhans cells III. Induction of T lymphocyte response to nickel sulphate in sensitized individuals. Br J Dermatol (1980) 0.86
Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo. Br J Cancer (2003) 0.86
Mysterious disappearance of an allogenic anterior cruciate ligament graft--a case of allergy against altered collagen. Allergy (2006) 0.86
T cells isolated from positive epicutaneous test reactions to amoxicillin and ceftriaxone are drug specific and cytotoxic. J Invest Dermatol (2000) 0.86
The HECA-452 epitope is highly expressed on lymph cells derived from human skin. Br J Dermatol (1999) 0.85
Predominance of T lymphocytes in the dermal infiltrate of atopic dermatitis. Br J Dermatol (1979) 0.85
T cell involvement in cutaneous drug eruptions. Clin Exp Allergy (2001) 0.85
Increased levels of inflammatory cytokines in human skin lymph derived from sodium lauryl sulphate-induced contact dermatitis. Br J Dermatol (1992) 0.84
[Treatment of linear scleroderma with water-filtered infrared-A irradiation]. Hautarzt (2007) 0.84
Effect of UVA and PUVA on alloactivating and antigen-presenting capacity of human epidermal Langerhans cells. Photodermatol (1987) 0.84
Characterization of human skin-derived CD1a-positive lymph cells. Arch Dermatol Res (1999) 0.84
An anti-human T-lymphocyte antiserum: in situ identification of T cells in the skin of delayed-type hypersensitivity reactions, chronic photosensitivity dermatitis, and mycosis fungoides. Clin Immunol Immunopathol (1979) 0.84
Dermatitis herpetiformis: lymphocytes, immunoglobulins and complement factors in peripheral blood. Acta Derm Venereol (1979) 0.84
Autologous suction blister grafting for chronic leg ulcers. J Eur Acad Dermatol Venereol (2008) 0.83
Topical photodynamic therapy in verrucae. A pilot study. Dermatology (1995) 0.83
In vitro and in vivo comparison of two different light sources for topical photodynamic therapy. Br J Dermatol (2006) 0.82
Successful treatment of pityriasis lichenoides with topical tacrolimus. Br J Dermatol (2004) 0.82
Acute generalized exanthematic pustulosis: a case and an overview of side effects affecting the skin caused by celecoxib and other COX-2 inhibitors reported so far. Dermatology (2004) 0.82
Oral prednisolone induced acute generalized exanthematous pustulosis due to corticosteroids of group A confirmed by epicutaneous testing and lymphocyte transformation tests. Dermatology (2006) 0.82
Reduced number of Langerhans cells in oral mucosal washings from HIV-1 seropositives. J Oral Pathol Med (1994) 0.82
Reduced number of CD1a+ cells in cutaneous B-cell lymphoma. Am J Clin Pathol (2001) 0.81
Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM-CSF as adjuvant. Exp Dermatol (2001) 0.81
CD1a-positive dendritic cells transport the antigen DNCB intracellularly from the skin to the regional lymph nodes in the induction phase of allergic contact dermatitis. Arch Dermatol Res (2001) 0.81
Apligraf--a living human skin equivalent for the treatment of chronic wounds. Int J Artif Organs (2000) 0.81
Characterization of the cellular infiltrate during successful topical treatment of lentigo maligna with imiquimod. Br J Dermatol (2004) 0.81
Variable pulsed light is less painful than light-emitting diodes for topical photodynamic therapy of actinic keratosis: a prospective randomized controlled trial. Br J Dermatol (2007) 0.81
Outer root sheath (ORS) cells organize into epidermoid cyst-like spheroids when cultured inside Matrigel: a light-microscopic and immunohistological comparison between human ORS cells and interfollicular keratinocytes. Cell Tissue Res (1994) 0.81
Large increase of Langerhans cells in human skin lymph derived from irritant contact dermatitis. Br J Dermatol (1993) 0.81
Evidence for Fc IgG receptors and complement factor C3b receptors in human choroid plexus. Clin Immunol Immunopathol (1979) 0.81
[The tick Ixodes ricinus, a spirochaeta vector]. Tidsskr Nor Laegeforen (1987) 0.81
An application of propensity score methods to estimate the treatment effect of corticosteroids in patients with severe cutaneous adverse reactions. Pharmacoepidemiol Drug Saf (2010) 0.80
Increased lipopolysaccharide-induced tumour necrosis factor-alpha, interferon-gamma and interleukin-10 production in atopic dermatitis. Br J Dermatol (2007) 0.80
Combined dermatofibroma: co-existence of two or more variant patterns in a single lesion. Histopathology (2000) 0.80
Soluble factors from human hair papilla cells and dermal fibroblasts dramatically increase the clonal growth of outer root sheath cells. Arch Dermatol Res (1993) 0.80
Phenotypic modulation of human hair matrix cells (trichocytes) by environmental influence in vitro and in vivo. Epithelial Cell Biol (1993) 0.80
Increased coexpression of eotaxin and interleukin 5 in bullous pemphigoid. Acta Derm Venereol (2001) 0.80
[Skin changes in diabetes mellitus]. Hautarzt (2004) 0.80
Proliferation and differentiation of cultured human follicular keratinocytes are not influenced by biotin. Arch Dermatol Res (1996) 0.80
Kaposi's sarcoma as manifestation of immunosuppression in organ transplant recipients. Dermatology (1997) 0.80
Regulation of the melanoma cell adhesion molecule gene in melanoma: modulation of mRNA synthesis by cyclic adenosine monophosphate, phorbol ester, and stem cell fFactor/c-kKit signaling. J Invest Dermatol (1999) 0.79
Combination of 10% EDTA, Photosan, and a blue light hand-held photopolymerizer to inactivate leading oral bacteria in dentistry in vitro. J Appl Microbiol (2009) 0.79
In vitro infection of human epidermal Langerhans cells with HIV. Adv Exp Med Biol (1988) 0.79
HLA genotypes in a family with a case of homozygous C2 deficiency and discoid lupus erythematosus. Acta Derm Venereol (1986) 0.79
Effects of acute, low-dose UVB radiation on the induction of contact hypersensitivity to diphenylcyclopropenone in man. Arch Dermatol Res (1993) 0.79
5-aminolaevulinic acid photodynamic therapy in a transgenic mouse model of skin melanoma. Exp Dermatol (2005) 0.79